We read with interest the FUTURE study by Mohamed Abdel-Fattah and colleagues, which reported on the role and cost-effectiveness of urodynamic testing in women with refractory overactive bladder ...
Results from the PATHFINDER 2 trial of Grail's blood test for multiple cancers have shown greater efficacy and a lower rate of false alarms than in an earlier trial of the technology. The Galleri ...
We thank Manuela Tutolo and colleagues for commending the design of the FUTURE study and the robustness of its delivery, including the urodynamics quality control. We also thank Maurizio Serati and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback